Lifeboat Foundation

Summary: Novel resveratrol analogs rejuvenate aging human cells, lengthening their Full Explanation of Telomeres.

Telomeres are a unique segment of DNA that sits at the end of the chromosome. Telomeres have repetitive sequences that are recognized as the end of the chromosome but are only there to keep the chromosome from becoming frazzled or damaged. Moreover, every time the cell divides, the telomeres also divide. But sometimes the telomeres can become shorter. As they grow shorter, they act like a clock that lets the cell know how old it is. The length of the telomere is the molecular clock, predicted by Hayflick. The telomere mechanism limits the number of times a cell can divide without losing DNA. When telomeres become too short, the cells cease multiplying and either become senescent or die.

Moreover, one of the interesting features about telomeres is that in cancer cells stay immortal by keeping their telomeres long. That means that cancer cells can continue dividing, long after they should have reached the end of their lifespan. This is one of the tactics that cancer cells use to trick the body into letting them keep replicating. [Source – NHGRI and Wikipedia.].

Continue reading “Old Human Cells Rejuvenated with ‘Breakthrough’ Anti-Aging Discovery” »

When taken daily, rapamycin causes side effects, the most serious of which include an increased risk of infection due to immune suppression, elevated blood sugar, and an increased risk of type 2 diabetes. Some of the side effects of daily rapamycin therapy are extremely serious, occasionally causing death due to infections. The complete list of side effects reported by daily rapamycin users includes high cholesterol, high triglycerides, glucose intolerance, insulin resistance, new-onset diabetes, anemia, thrombocytopenia, gastrointestinal disorders, sinusitis, respiratory and urinary infections, testicular dysfunction, and skin problems.

Daily vs. Intermittent Rapamycin Therapy

Rapamycin therapy is promising. However, researchers still need to determine the dosage that provides health benefits while eliminating harmful side effects. Scientists think they have already found the answer because rapamycin behaves differently when taken daily, as opposed to intermittently.

Continue reading “Can a Revolutionary Rapamycin Therapy Slow Down Aging in Our Bodies?” »

Summary: (Video) A short animation from the journal Nature demonstrates revolutionary new additions to the CRISPR toolbox some call CRISPR 2.0. Scroll down for video. [This article first appeared on LongevityFacts. Follow us on Reddit | Google+ | Facebook. Author: Brady Hartman.]

Techniques to modify DNA in the genome have existed for several decades, and the original CRISPR-Cas9, called CRISPR 1.0, brought an era of faster, cheaper, and more efficient gene editing tools. A short video from the journal Nature shows you how scientists have revolutionized the original CRISPR-Cas9 system, significantly expanded its toolbox, creating a more powerful set of tools some call CRISPR 2.0. Genetic engineers have discovered how to make CRISPR perform new tricks such as improved gene editing, turning genes on and off, and making genes glow for research.

What are gene editing and crispr-cas9?

Continue reading “CRISPR 2.0: New Ways to Edit Genes in Our Body (video)” »

Summary: Will gene drive wipe out malaria-causing mosquitoes, or will the genetic technology that ‘spreads like wildfire’ cause a catastrophe? Gene drive raises hopes and fears as a team of scientists funded by the Bill & Melinda Gates Foundation are using it to wipe out the mosquitoes that carry malaria, to eradicate the disease. [This article first appeared on LongevityFacts. Follow us on Reddit | Google+ | Facebook. Author: Brady Hartman.]

In a basement lab at the Imperial College London (ICL), a group of researchers led by Andrew Hammond are on a mission to wipe out malaria. The scientists are funded by the Bill & Melinda Gates Foundation and are using a technology called gene drive – a souped-up form of genetic engineering designed to wipe out the mosquitoes that carry the disease.

The lab contains cages of mosquitoes modified with the gene drive, along with an additional gene that makes their eyes and other body parts glow red under laser light.

Continue reading “Microsoft’s Gates to Genetically Engineer Laser Lit Mosquitoes Using Gene Drive” »

Summary: Can a gene fuel obesity? Variants of a gene called ‘ankyrin-B’ – a gene carried by millions of Americans – could cause individuals to put on pounds through no fault of their own. [This article first appeared on LongevityFacts. Follow us on Reddit | Google+ | Facebook. Author: Brady Hartman]

We often attribute obesity to eating too much and exercising too little. However, the evidence is growing that at least some of our weight gain is predetermined by our genes. And if a simple genetic variant causes weight gain, then it’s a prime target for gene editing.

New research from the University of North Carolina suggests that variants in a gene called ankyrin-B, a gene carried by millions of Americans, could cause individuals to gain weight through no fault of their own.

Summary: Aubrey de Grey’s SENS foundation is both controversial and inspirational. Watch a 3-minute video of Aubrey, followed by a discussion of Dr. Aubrey de Grey’s revolutionary plans to reverse aging. [This article first appeared on LongevityFacts.com. Author: Brady Hartman. Follow us on Reddit | Google+ | Facebook. ]

Aubrey de Grey is on a mission to reverse aging and has a large group of followers who think he might do it.

Continue reading “Do Aubrey de Grey’s Revolutionary Plans to Reverse Aging Make SENS? (video)” »

Have you seen the clickbait campaign that focuses on the research of Dr. Steven Gundry. It employs a slimy, photo-tile lure that asks you to turn up your speakers and then hawks a product or service disguised as a breakthrough discovery. These scams force the viewer to stay on the page. Typically, there is no indication of how long the video is, or any way to skip forward,

Steven Gundry Food Pyramid

Passing judgement on Dr. Gundry’s evolutionary claims and diet recommendations begs for independent clinical studies, or at least the analysis and commentary of scholars in nutrition, gastroenterology and evolution. But, like Robert Atkins and Dean Ornish, Dr. Gundry seems earnest in his research and motives. I don’t think that he is selling anything other than his opinion.

Continue reading “Dr. Steven Gundry says plant-based diets are the problem” »

SENS Research Foundation co-founder Aubrey de Grey believes in a world in which we no longer age. At a London event, he explained that he believes the first person who will live to be 1,000 has already been born, and we’ll solve this “aging problem” within 20 years.

Aging has plagued biological organisms since life first began on planet Earth and it’s an accepted and universally understood part of life. Sure, things like climate change pose significant threats to society, but aging will almost certainly still exist even if we ever manage to stop damaging our environment.

Dr. Aubrey de Grey Summarizes Rejuvenation Research at the MIT Technology Review. To learn more about the work of Dr. Aubrey de Grey and the SENS Foundation visit http://www.sens.org/

Since the dawn of medicine, aging has been doctors’ foremost challenge. Three unsuccessful approaches to conquering it have failed: treating components of age-related ill health as curable diseases, extrapolating from differences between species in the rate of aging, and emulating the life extension that famine elicits in short-lived species. SENS Research Foundation is spearheading the fourth age of anti-aging research: the repair of age-related damage, that is, rejuvenation biotechnology.

The Strategies for Engineered Negligible Senescence (SENS) approach was first proposed in 2002. “Senescence,” here, refers to the actuarial phenomenon—the trend that individuals within a population suffer from an increasing morbidity and mortality rate in (typically exponential) relation to their chronological age. “Negligible” is used in a statistical sense: we consider a level of senescence negligible if no age-related contribution to mortality is statistically demonstrable within a population, given the “background noise” of age-independent mortality (such as unfortunate encounters with motor vehicles). Finally, by “Engineered,” we indicate that this state is achieved by the deliberate application of biomedical therapies, and is not the normal situation. The goal of SENSE is thus unambiguously defined; we seek methods to convert a population experiencing a non-negligible level of senescence into one experiencing a negligible level.

Continue reading “Undoing Aging with Molecular and Cellular Damage Repair” »